Carillon Eagle Growth & Income Fund highlighted stocks like Medtronic plc (NYSE:MDT), in the second quarter 2024 investor letter. Medtronic plc (NYSE:MDT) develops, manufactures, and distributes ...

Medical device giant Medtronic (NYSE: MDT) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue ...

Ajizian held multiple positions in his more than nine years at Medtronic. In 2020, the company made Ajizian CMO of patient monitoring. Two years later, Medtronic outlined plans to spin off its ...

Researchers from Shenzhen University and affiliated organizations detailed the preclinical characterization of a synergistic intravesical instillation of fenbendazole (FBZ) and CRISPR-Cas13a-based ...

Medtronic (NYSE:MDT) has had a great run on the share market with its stock up by a significant 13% over the last month. We, however wanted to have a closer look at its key financial indicators as ...

Medtronic delivered a strong first-quarter earnings report. The company benefits from continued market adoption of several new product launches over the past year. The stock looks attractive ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...

Synergy Scaffolding Services and its related entities have not only secured union backing for multiple enterprise bargaining agreements (EBAs) but, according to union and industry sources ...

The first-of-its-kind Medtronic Percept deep brain stimulation (DBS) system is poised to take another big step for neurostimulation technology. When it won FDA approval in 2020, Percept PC was the ...

The Percept RC deep brain stimulation system [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that the FDA approved expanded MRI labeling for its deep brain stimulation (DBS ...